Antitumoral <scp>RNA</scp> ‐targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies-Reference-Cited by-同舟云学术

Antitumoral RNA ‐targeted oligonucleotide therapeutics: The third pillar after small molecule inhibitors and antibodies

Author:

Taniguchi Hiroaki¹²^ORCID,Suzuki Yasunori¹,Imai Kohzoh³,Adachi Yasushi⁴^ORCID

Affiliation:

1. Keio Cancer Center Keio University School of Medicine Tokyo Japan

2. Innovation Center of NanoMedicine Kawasaki Institute of Industrial Promotion Kawasaki Japan

3. Institute for Genetic Medicine Hokkaido University Sapporo Japan

4. Department of Gastroenterology and Hepatology Sapporo Medical University School of Medicine Sapporo Japan

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Princess Takamatsu Cancer Research Fund

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

Reference52 articles.

1. From antisense RNA to RNA modification: therapeutic potential of RNA‐based technologies;Adachi H;Biomedicine,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献